These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2984914)

  • 21. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(13):912-6. PubMed ID: 2845768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
    Shannon RP; Friedrich S; Mathier M; Knight DR
    Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional hemodynamics following captopril therapy.
    Am J Med; 1984 May; 76(5B):1-119. PubMed ID: 6375359
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of captopril on renal vascular tone in patients with essential hypertension.
    Mimran A; Brunner HR; Turini GA; Waeber B; Brunner D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():421s-423s. PubMed ID: 232029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril and renal function.
    Reubi FC
    Contrib Nephrol; 1984; 43():159-70. PubMed ID: 6386324
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the acute and chronic hemodynamic effects of captopril and guanethidine in spontaneously hypertensive rats.
    Ferrone RA; Heran CL; Antonaccio MJ
    Clin Exp Hypertens (1978); 1980 Feb; 2(2):247-72. PubMed ID: 6998684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic profile of captopril treatment in various forms of hypertension.
    de Bruyn JH; Man in't Veld AJ; Wenting GJ; Derkx FH; Schalekamp MA
    Eur J Clin Pharmacol; 1981; 20(3):163-8. PubMed ID: 7026256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term captopril therapy: evolving hemodynamic effects.
    Sullivan JM; Taylor JC; Patrick DR; Johnson JG; Ratts TE; Muirhead EE
    J Clin Pharmacol; 1982 Oct; 22(10):450-8. PubMed ID: 6757280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute filling pattern changes of the failing left ventricle after captopril as related to ventricular structure.
    Barbier P; Tamborini G; Alioto G; Pepi M
    Cardiology; 1996; 87(2):153-60. PubMed ID: 8653733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate hemodynamic effects of urapidil in patients with essential hypertension.
    Kobrin I; Amodeo C; Ventura HO; Messerli FH; Frohlich ED
    Am J Cardiol; 1985 Mar; 55(6):722-5. PubMed ID: 3976516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.